EHA Library - The official digital education library of European Hematology Association (EHA)

RESISTANT THROMBOSIS WITH STANDARD HEPARIN TREATMENT: ANTI-THROMBIN III DEFICIENCY
Author(s): ,
Yasemin Altuner Torun
Affiliations:
Pediatric hematology,Kayseri education and research hospital,Kayseri,Turkey
,
Mahmut can Serbetci
Affiliations:
Pediatrics,Kayseri education and research hospital,Kayseri,Turkey
Gamze Poyrazoglu
Affiliations:
Pediatric neurology,Kayseri education and research hospital,Kayseri,Turkey
(Abstract release date: 05/21/15) EHA Library. Altuner Torun Y. 06/12/15; 103001; PB1699 Disclosure(s): Kayseri Education and Research Hospital
Pediatric Hematology
Assoc. Prof. Yasemin Altuner Torun
Assoc. Prof. Yasemin Altuner Torun
Contributions
Abstract
Abstract: PB1699

Type: Publication Only

Background

Sinus vein thrombosis is a type of stroke and   a multifactorial disease that usually manifested by non-specific symptoms in children.In most cases there is an underlying prothrombotic risk factors or a combination of many clinical reasons. The prevalence of antithrombin III deficiency in patients with thrombosis incidence is 0.02%, as this rate in normal populations is  1% .In this article, we will discuss a case with antithrombin III deficiency that he do not receive the standard heparin treatment.  A twenty years old male patient with sudden onset of headache, dizziness, nausea and vomiting was admitted to our clinic.His physical examination and vital findings were stable. His cranial MRI showed thrombosis of superior sagittal sinus and the left transverse and sigmoid sinuses.Clexane(enoxaparin) started 2x1 mg/kg/daily and  contunied for 15 days.There was not any recanalization in the thrombosis veins on his repeated cranial MRI after the 15 days treatment.The patient's anti-thrombin  III activity was 34.8%  as other normal thrombophilia tests. Antithrombin  III deficiency was diagnosed. Coumadin(warfarin) treatment was started due to ineffective low molecular weight heparins. The possibility of antithrombin III deficiency should be considered when a low molecular weight heparin therapy is not effective in  the follow up patients with the diagnosis of thrombosis.
Sinus vein thrombosis is a type of stroke and   a multifactorial disease that usually manifested by non-specific symptoms in children.In most cases there is an underlying prothrombotic risk factors or a combination of many clinical reasons. 



Aims
The prevalence of antithrombin III deficiency in patients with thrombosis incidence is 0.02%, as this rate in normal populations is  1% .In this article, we will discuss a case with antithrombin III deficiency that he do not receive the standard heparin treatment.

Methods
 A twelve years old male patient with sudden onset of headache, dizziness, nausea and vomiting was admitted to our clinic.His physical examination and vital findings were stable. His cranial MRI showed thrombosis of superior sagittal sinus and the left transverse and sigmoid sinuses.Clexane(enoxaparin) started 2x1 mg/kg/daily and  contunied for 15 days.There was not any recanalization in the thrombosis veins on his repeated cranial MRI after the 15 days treatment.The patient's anti-thrombin  III activity was 34.8%  as other normal thrombophilia tests. Antithrombin  III deficiency was diagnosed. 

Results

Antithrombin  III deficiency was diagnosed. Coumadin(warfarin) treatment was started due to ineffective low molecular weight heparins. 



Summary
The possibility of antithrombin III deficiency should be considered when a low molecular weight heparin therapy is not effective in  the follow up patients with the diagnosis of thrombosis.

Keyword(s): Children, Heparin, Thrombosis

Session topic: Publication Only
Abstract: PB1699

Type: Publication Only

Background

Sinus vein thrombosis is a type of stroke and   a multifactorial disease that usually manifested by non-specific symptoms in children.In most cases there is an underlying prothrombotic risk factors or a combination of many clinical reasons. The prevalence of antithrombin III deficiency in patients with thrombosis incidence is 0.02%, as this rate in normal populations is  1% .In this article, we will discuss a case with antithrombin III deficiency that he do not receive the standard heparin treatment.  A twenty years old male patient with sudden onset of headache, dizziness, nausea and vomiting was admitted to our clinic.His physical examination and vital findings were stable. His cranial MRI showed thrombosis of superior sagittal sinus and the left transverse and sigmoid sinuses.Clexane(enoxaparin) started 2x1 mg/kg/daily and  contunied for 15 days.There was not any recanalization in the thrombosis veins on his repeated cranial MRI after the 15 days treatment.The patient's anti-thrombin  III activity was 34.8%  as other normal thrombophilia tests. Antithrombin  III deficiency was diagnosed. Coumadin(warfarin) treatment was started due to ineffective low molecular weight heparins. The possibility of antithrombin III deficiency should be considered when a low molecular weight heparin therapy is not effective in  the follow up patients with the diagnosis of thrombosis.
Sinus vein thrombosis is a type of stroke and   a multifactorial disease that usually manifested by non-specific symptoms in children.In most cases there is an underlying prothrombotic risk factors or a combination of many clinical reasons. 



Aims
The prevalence of antithrombin III deficiency in patients with thrombosis incidence is 0.02%, as this rate in normal populations is  1% .In this article, we will discuss a case with antithrombin III deficiency that he do not receive the standard heparin treatment.

Methods
 A twelve years old male patient with sudden onset of headache, dizziness, nausea and vomiting was admitted to our clinic.His physical examination and vital findings were stable. His cranial MRI showed thrombosis of superior sagittal sinus and the left transverse and sigmoid sinuses.Clexane(enoxaparin) started 2x1 mg/kg/daily and  contunied for 15 days.There was not any recanalization in the thrombosis veins on his repeated cranial MRI after the 15 days treatment.The patient's anti-thrombin  III activity was 34.8%  as other normal thrombophilia tests. Antithrombin  III deficiency was diagnosed. 

Results

Antithrombin  III deficiency was diagnosed. Coumadin(warfarin) treatment was started due to ineffective low molecular weight heparins. 



Summary
The possibility of antithrombin III deficiency should be considered when a low molecular weight heparin therapy is not effective in  the follow up patients with the diagnosis of thrombosis.

Keyword(s): Children, Heparin, Thrombosis

Session topic: Publication Only

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies